← Dashboard
Aug 08, 2026 06:54 PM ET
Catalyst
FDA/Bio
EYEPOINT: PHASE 3 DESIGN CREATES A MORE VALUABLE DURABILITY STORY - SEEKINGALPHA
EYEPOINT: PHASE 3 DESIGN CREATES A MORE VALUABLE DURABILITY STORY - SEEKINGALPHA
What changed
Why it matters
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →